Medtech

Health Catalyst Finalizes Acquisition of Leading Care Management Company, Lumeon

SALT LAKE CITY, Aug. 8, 2024 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst,"  Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has successfully completed its acquisition of Lumeon Limited ("Lumeon"), a digital health company with operations in the U.S. [...]

2024-08-12T21:21:27+01:00August 12th, 2024|All News, Company News, Investment, Medtech|

Kestra Medical Technologies Announces $196 Million Oversubscribed Financing Round

KIRKLAND, Wash. July 24, 2024 08:00 AM Eastern Daylight--(BUSINESS WIRE)-- Kestra Medical Technologies, Inc., a privately held wearable medical device and digital healthcare company, today announced an oversubscribed $196 million funding round to support the expansion of their commercial organization and advance its mission of protecting at-risk patients with [...]

2024-07-29T17:05:17+01:00July 29th, 2024|All News, Company News, Investment, Medtech|

CeQur Simplicity™, a Wearable Mealtime Insulin Delivery Device, Obtains FDA-Clearance for 4 Days of Wear to Further Simplify Diabetes Management

The CeQur Simplicity patch is now FDA-cleared for up to 4 days of wear. Each patch replaces up to 12 injections further simplifying mealtime insulin management. Horw, Switzerland, June 18, 2024 - CeQur®, a medical device company dedicated to simplifying insulin delivery for individuals on multiple daily injections, announces [...]

2024-06-20T20:45:44+01:00June 20th, 2024|All News, Company News, Investment, Medtech|

Miach Orthopaedics Raises $20 Million in Series B Extension

WESTBOROUGH, Massachusetts – April 2, 2024 – Miach Orthopaedics, Inc., a company transforming the treatment of anterior cruciate ligament (ACL) tears from reconstruction to restoration with the Bridge-Enhanced ACL Restoration (BEAR®) Implant, today announced closing of a $20 million Series B extension financing round. The funds will support commercial [...]

2024-04-03T13:48:59+01:00April 3rd, 2024|All News, Company News, Medtech|

Viewpoint on the FDA marketing authorization for MIRA

Following the welcome announcement that Virtual Incision has received FDA marketing authorization for MIRA, we spoke to Fernando Pacheco, investment director at Endeavour Vision, and board director at Virtual Incision to understand what the breakthrough will mean for healthcare providers, surgeons and patients alike… Let’s start with [...]

2024-03-01T13:46:14+00:00March 1st, 2024|All News, Blog, Investment, Medtech|

Virtual Incision Receives FDA Authorization for the MIRA Surgical System as the First Miniaturized Robotic-Assisted Surgery Device

New category challenges industry standards in soft tissue robotic-assisted surgery and has the potential to expand access to minimally invasive care De Novo premarket review pathway establishes initial indication for adults undergoing colectomy procedures and lays the foundation for expansion into other abdominal procedures LINCOLN, Neb. – February [...]

2024-02-26T09:01:21+00:00February 26th, 2024|All News, Company News, Investment, Medtech|

Nalu Medical, Inc. Announces $65 Million Equity Financing to Advance Treatment for Chronic Neuropathic Pain

Proceeds will accelerate commercial growth and expand clinical and health-economic evidence for the innovative Nalu neurostimulation system featuring the revolutionary micro-IPG.™ Series E round led by Novo Holdings and joined by all existing significant investors. CARLSBAD, Calif (BUSINESS WIRE) January 3, 2024 - Nalu Medical Inc. (Nalu), a private company [...]

2024-02-27T15:08:24+00:00January 3rd, 2024|All News, Company News, Medtech|

Nalu Medical, Inc., Announces Positive Results of US Spinal Cord Stimulation Clinical Study in Pain Physician Journal

November 29, 2023 12:00 PM Eastern Standard Time CARLSBAD, Calif.--Nalu Medical, Inc (“Nalu”) is a Carlsbad, California-based company that has successfully miniaturized neurostimulation implants for the management of chronic intractable pain across a variety of targets with both spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) indications. Today [...]

2024-02-27T15:22:23+00:00December 6th, 2023|All News, Company News, Medtech|
Go to Top